Our U.S. patent of MOMMYTOO/MOMAID has officially been granted.

We are proud to announce that our U.S. patent US 12,268,712B2 has officially been granted. This milestone recognizes our innovation and dedication in the field of women’s health and specifically postnatal regeneration. 

The newly granted patent strengthens our intellectual property portfolio and supports the continued development of our flagship product Mommytoo/Momaid. It also opens new opportunities for partnerships and global expansion. We thank our talented team and collaborators for their relentless efforts in making this achievement possible.